The goal of this study was to utilize predictors for diagnosis conversion to AD based on integrating resting-state functional MRI (rs-fMRI) connectivity analysis and structural MRI (sMRI).
Here, we review current and emerging concepts of the MRI-defined multiple sclerosis lesion phenotype, advanced longitudinal imaging techniques that permit in-vivo exploration of dynamic microstructural change within lesions and emerging MRI measures of lesion repair.
Medtronic has received FDA approval for a portfolio of quadripolar cardiac resynchronization therapy-pacemakers (CRT-Ps) that improve therapy delivery for patients...
The twelve recommendations are intended to advise physicians on the use of imaging modalities when making a clinical diagnosis, and when to apply imaging for monitoring of disease activity and damage.
Medtronic has announced CE Mark approval and European launch of the Evera MRI SureScan implantable cardioverter defibrillator (ICD) System, the...
The FDA has approved Medtronic Amplia MRI Quad CRT-D SureScan and Compia MRI Quad CRT-D SureScan systems for the treatment...
The MRI-Guided Radiation Therapy System, from ViewRay, has received US FDA 510(k) premarket notification clearance. The system features a combination...
Boston Scientific has received FDA approval for the EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance...
The clinical course of relapse-onset multiple sclerosis is highly variable. Demographic factors, clinical features and global brain T2 lesion load have limited value in counselling individual patients. We investigated early MRI predictors...
The FDA has cleared the M2 Compact MRI system, from Aspect Imaging, for diagnostic Imaging of the wrist. Unlike conventional...